Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04998656 · ClinicalTrials.gov registry record · NA
Werewolf Flow 50 During ACL Reconstruction
A NA study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 182
- Enrollment target
NCT04998656 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 182 participants.
The verdict
NCT04998656, a NA study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 182 participants
- Enrollment target
Study Summary
The aim of this study is to compare the outcomes, ease of use, and cost of the Werewolf FLOW50 device to the institutional standard of care which is does not include the use of electrocautery devices during anterior cruciate ligament reconstruction (ACLR) surgery in patients 12-18 years of age using a randomized control trial design. The investigators hypothesize that a lower proportion of participants who undergo ACLR and are randomized to the Werewolf FLOW50 procedure will experience post-operative arthrofibrosis compared to those randomized to standard of care (control group).
Interventions
- OTHER Control
- DEVICE Werewolf FLOW 50
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2021-07-12 |
| Est. Completion | 2024-11-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04998656
The ClinicalTrials.gov registry entry for NCT04998656 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT04998656 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04998656 about?
NCT04998656 is a clinical study titled "Werewolf Flow 50 During ACL Reconstruction". The aim of this study is to compare the outcomes, ease of use, and cost of the Werewolf FLOW50 device to the institutional standard of care which is does not include the use of electrocautery devices during anterior cruciate ligament reconstruction (ACLR) surgery in patients 12-18 years of age using...
What is the current status of trial NCT04998656?
This trial is currently completed. It is a NA study. The enrollment target is 182 participants. The study started on 2021-07-12. Estimated completion is 2024-11-02.
What interventions are being tested in trial NCT04998656?
The interventions under investigation include: Control (OTHER), Werewolf FLOW 50 (DEVICE).
Who is sponsoring clinical trial NCT04998656?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.